Home / Intelligence / Webinars / How to Generate Evidence to Drive Differentiation for Your Asset in a Competitive Market
Available On Demand
Demonstrating and communicating the value story to clinicians and payers is critical for successful commercialization, but there are many scenarios where new products may struggle to differentiate themselves. If you have a better mousetrap, how do you demonstrate value to support pricing, access, adoption and reimbursement?
The HEOR Evidence Strategy team at Trinity Life Sciences will conduct a webinar to explore this important question and share several case studies where we worked with companies facing this challenge. We will also discuss how evidence generation needs vary across the product life cycle, what is needed in preparation for launch and the opportunities and challenges in evidence dissemination.
Come learn with the Trinity Evidence Strategy team!
Key Topics for Case Studies
- Differentiation based on safety and tolerability when efficacy is similar
- Defining and illustrating new value drivers in a market with multiple therapeutics with similar mechanisms of action
- Demonstrating how product characteristics beyond efficacy and safety influence patient preferences and adherence
Complete the form below to watch the on-demand webinar.
The Future of AI for Market Access: An ISPOR US 2023 Recap
This year Trinity team members at ISPOR 2023 attended several symposia and presentations on the use of Artificial Intelligence (AI) to support biopharma evidence generation. Among many industry trends, experts anticipate that AI and machine learning will increasingly be leveraged to identify optimal patient populations and expedite the path toward personalized medicine. Pioneering New Frontiers […]
ISPOR 2023 Trinity Panel: Enabling Patient Access to Digital Therapeutics – The Optimal Approach?
Monica Martin de Bustamante, Sr. Partner of Trinity’s Evidence, Value, Access, and Pricing (EVAP) team, moderated an exciting conversation at ISPOR 2023 Global in Boston earlier this month. Monica spoke with Lisa Marsch, Ph.D., Benjamin Parcher, PharmD, MS, and Fulton Velez, MD, MS, MBA, all experts in the field of Digital Therapeutics (DTx), about the […]
Generating Robust Insights to Develop a Compelling Value Story with RWE
Available On Demand
The unprecedented availability of rich RWE data sources gives HEOR, Value and Access and Medical leaders the opportunity to be more intentional than ever before. High-quality, compelling evidence is now a necessity, not just for high-value therapies playing in the rare disease space—but also more broadly, to show reduced unmet needs, health care resource utilization […]